2.4.0.84022 - Disclosure - Summary of Significant Accounting Policies (Details 3)truefalsefalse1false falsefalseD2013Q2YTDhttp://www.sec.gov/CIK0001274792duration2013-01-01T00:00:002013-06-30T00:00:00ItemStandardhttp://www.merrimackpharma.com/20130630itemmack01true 1us-gaap_AccountingPoliciesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Summary of Significant Accounting Policies2false 2mack_NumberOfIssuesToLimitInvestmentAmountAsPerInvestmentPolicymack_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse11falsefalsefalsexbrli:integerItemTypeintegerRepresents the number of issues in which entity will limit its investment as per investment policy so as to reduce the credit risk.No definition available.false256Number of issues with limited investment as per investment policyfalseSummary of Significant Accounting Policies (Details 3)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.merrimackpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails312